Shares of NKTR Therapeutics (NKTR) are down .48 to 12.43.? NKTR is trading near the higher end of the 52-week range.
Today paper traded 1,900 NKTR Mar 13 calls for 1.30. ?ADV is 459 contracts.? The OI is 0 contracts.
The volume traded in one block with total volume on the day 2757 by mid-afternoon. The buyer lifted the offer in a .40 wide market at the time with the IV up 10 points in March.? This is a very aggressive opening call buy, most likely to get long the underlying.? There should be news in the March cycle.
30-day implied volatility is 65%.? ?10-day implied volatility is 71%.? 30 day implied volatility is trading below the 10 Day Historical volatility.
Nektar Therapeutics is a clinical-stage biopharmaceutical company which develops a pipeline of drug candidates that utilize company platforms.?